Infectious Diseases

December 15, 2025

Antibody research may lead to broadly protective flu vaccine

These findings could lead to the development of cross-reactive and neutralizing antibody therapies for individuals who are severely ill from the flu.

By Bill Snyder
December 11, 2025

Experts call for better adherence to guidelines for antiviral prescribing for children at higher risk of severe influenza

Researchers found a substantial gap between recommendations and real-world treatment practices in pediatric EDs (emergency departments) across the country.

By Jessica Pasley
December 1, 2025

Timothy Sterling receives $5.7 million to study tuberculosis transmission

Using molecular and other data from both the bacterial and human sides of the equation, a multi-institutional team will develop prediction models of TB transmission.

By Paul Govern
November 17, 2025

VUMC’s Robert Carnahan named a 2025 Master Innovator

He is a translational scientist and antibody engineer who specializes in rapid therapeutic development for emerging infectious diseases.
November 11, 2025

Drug resistant infections are on the rise: Experts emphasize education, awareness

Teams at VUMC and Monroe Carell are focused on reaching more clinicians, patients and families through the Vanderbilt Antimicrobial Stewardship Program.

By Jessica Pasley
H. Keipp Talbot, MD, MPH
November 5, 2025

Keipp Talbot wins Anthony Fauci Courage in Leadership Award

Bestowed by the Infectious Diseases Society of America, the award “celebrates individuals who inspire and encourage others to make a difference.”

By Paul Govern
November 4, 2025

AI can speed antibody design to thwart novel viruses: study

While the study focused on development of antibody therapeutics against existing and emerging viral threats, the implications of the research are much broader.
By Bill Snyder
November 4, 2025

Anna Person leads HIV Medical Association board of directors

HIVMA was created in 2001 by the Infectious Diseases Society of America "to advance a comprehensive and humane response to the HIV pandemic, informed by science and social justice."
By Paul Govern
November 3, 2025

Artificial HIV patients do their part for science

To speed HIV research, VUMC scientists are drafting droves of people who do not exist to serve as research subjects.
By Paul Govern
November 3, 2025

Prescribing with purpose

A Vanderbilt University Medical Center study finds unnecessary antibiotic prescriptions in hospitalized children and highlights opportunity for antibiotic stewardship.
By Chelsea N. Campbell
October 22, 2025

New sepsis therapy developed at VUMC edges closer to the clinic

Jacek Hawiger and his colleagues report that a “peptide genomic therapy” given in combination with an antibiotic nearly doubles survival rates from sepsis in an animal model, compared to treatment with antibiotic alone.
By Bill Snyder
September 23, 2025

Flu vaccines available now: Protect yourself this fall

With respiratory virus season approaching, health experts at Vanderbilt University Medical Center are urging Middle Tennesseans to protect themselves and their families by getting vaccinated against the flu. For VUMC employees, the Occupational Health Clinic is facilitating multiple influenza vaccination options.
By Paul Govern
August 30, 2025

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

RSV causes substantial seasonal illness during fall and winter in the U.S., with an estimated 100,000-150,000 hospitalizations and 4,000-8,000 deaths.
By Craig Boerner
1 2 3 … 12